JPH11511654A - 比較的非分化の細胞の連続的選択的クローン原性増大 - Google Patents

比較的非分化の細胞の連続的選択的クローン原性増大

Info

Publication number
JPH11511654A
JPH11511654A JP8535103A JP53510396A JPH11511654A JP H11511654 A JPH11511654 A JP H11511654A JP 8535103 A JP8535103 A JP 8535103A JP 53510396 A JP53510396 A JP 53510396A JP H11511654 A JPH11511654 A JP H11511654A
Authority
JP
Japan
Prior art keywords
cells
population
chamber
cell
fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP8535103A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11511654A5 (2
Inventor
クラウス，モレイ
フライバー，ジイ．ジル
Original Assignee
ティー．ブリーダーズ，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ティー．ブリーダーズ，インコーポレイテッド filed Critical ティー．ブリーダーズ，インコーポレイテッド
Publication of JPH11511654A publication Critical patent/JPH11511654A/ja
Publication of JPH11511654A5 publication Critical patent/JPH11511654A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/16—Particles; Beads; Granular material; Encapsulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95—Protein-free medium and culture conditions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Sustainable Development (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
JP8535103A 1995-05-19 1996-05-17 比較的非分化の細胞の連続的選択的クローン原性増大 Ceased JPH11511654A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/446,165 1995-05-19
US08/446,165 US5674750A (en) 1995-05-19 1995-05-19 Continuous selective clonogenic expansion of relatively undifferentiated cells
PCT/US1996/007195 WO1996036696A1 (en) 1995-05-19 1996-05-17 Continuous selective clonogenic expansion of relatively undifferentiated cells

Publications (2)

Publication Number Publication Date
JPH11511654A true JPH11511654A (ja) 1999-10-12
JPH11511654A5 JPH11511654A5 (2) 2004-07-08

Family

ID=23771556

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8535103A Ceased JPH11511654A (ja) 1995-05-19 1996-05-17 比較的非分化の細胞の連続的選択的クローン原性増大

Country Status (6)

Country Link
US (1) US5674750A (2)
EP (1) EP0830448A4 (2)
JP (1) JPH11511654A (2)
AU (1) AU5797496A (2)
CA (1) CA2221623A1 (2)
WO (1) WO1996036696A1 (2)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925567A (en) 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
US6100043A (en) * 1995-08-04 2000-08-08 The Perkin-Elmer Corporation Recombinant clone selection system
US5843656A (en) * 1995-08-07 1998-12-01 The Perkin-Elmer Corporation Recombinant clone selection system
US5750346A (en) * 1995-08-07 1998-05-12 The Perkin-Elmer Corporation Host organism capture
EP0973530A4 (en) * 1996-12-10 2002-01-16 Hadasit Med Res Service SERUM-DERIVING FACTOR FOR INDUCING CELL DIFFERENTIATION AND ITS MEDICAL USES
US20020034819A1 (en) * 1998-02-23 2002-03-21 Alan K. Smith Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
CA2344653A1 (en) 1998-09-29 2000-04-06 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
US7585323B2 (en) * 2000-05-05 2009-09-08 Medlden, Llc In vitro mechanical loading of musculoskeletal tissues
US7811557B1 (en) 2000-10-27 2010-10-12 Viacell, Inc. Methods for improving central nervous system functioning
US7452529B2 (en) * 2001-07-23 2008-11-18 Viacell, Inc. Treatment of muscular dystrophy with cord blood cells
WO2003039232A2 (en) * 2001-10-26 2003-05-15 Large Scale Biology Corporation Endothelial cell derived hemotopoietic growth factor
AU2002350139A1 (en) * 2001-11-09 2003-05-26 Viacell, Inc. Production of cell suspensions
US7169278B2 (en) * 2002-01-21 2007-01-30 Tecan Trading Ag Apparatus and separation media for separating particles in free-flow electrophoresis
US7169275B2 (en) * 2002-01-21 2007-01-30 Tecan Trading Ag Method for separating particles in free flow electrophoresis
IL152904A0 (en) * 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
WO2003062404A1 (en) 2002-01-25 2003-07-31 Gamida-Cell Ltd. Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
EP1485464A4 (en) * 2002-03-18 2006-11-29 Gamida Cell Ltd METHODS OF INDUCING DIFFERENTIATION IN EX VIVO EXPANDED STEM CELLS
US20040028661A1 (en) * 2002-08-07 2004-02-12 Bartelmez Stephen H. Expansion of cells using thrombopoietin and anti-transforming growth factor-beta
US20050054097A1 (en) * 2002-11-17 2005-03-10 Tony Peled EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
AU2004217699B2 (en) * 2003-03-07 2008-07-03 Gamida-Cell Ltd. Expansion of renewable stem cell populations using modulators of PI 3-kinase
IL161903A0 (en) * 2003-07-17 2005-11-20 Gamida Cell Ltd Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs
JP2007520462A (ja) * 2003-12-19 2007-07-26 バイアセル インコーポレーティッド ヒト臍帯血由来多能性細胞の疾患の処置のための使用方法
US20070298015A1 (en) * 2004-04-28 2007-12-27 Viacell, Inc. Treatment of Muscular Dystrophy with Mobilized Peripheral Blood Pluripotent Cells
EP1799812A4 (en) 2004-09-16 2009-09-09 Gamida Cell Ltd EX VIVO CULTIVATION METHODS OF STEM CELLS AND PRECURSOR BY CO-CULTURE WITH MESENCHYMAL CELLS
EP1877547B1 (en) 2005-05-04 2012-08-08 Commonwealth Scientific and Industrial Research Organisation Selecting, culturing and creating lineage committed hematopoietic stem cells
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
JP2012533519A (ja) 2009-06-18 2012-12-27 エムシーツー セル エイピーエス 骨髄細胞外マトリックス抽出物およびその治療上の使用
US8895291B2 (en) 2010-10-08 2014-11-25 Terumo Bct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
CN104204192A (zh) 2012-02-13 2014-12-10 加米达细胞有限公司 间充质干细胞调理的基质及其产生和使用方法
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
JP6612227B2 (ja) 2013-11-16 2019-11-27 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
CN115011556B (zh) * 2022-08-10 2022-10-25 山东省齐鲁干细胞工程有限公司 一种脐带血造血干细胞的分离方法
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514499A (en) * 1983-02-04 1985-04-30 Corning Glass Works Cell culture using a monolithic support
US5004681B1 (en) * 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
WO1991016116A1 (en) * 1990-04-23 1991-10-31 Cellpro Incorporated Immunoselection device and method
ATE220715T1 (de) * 1991-10-23 2002-08-15 Nexell Therapeutics Inc Verfahren zur selektiven vermehrung von cd34 positiven zellen
US5460964A (en) * 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
DE4240635C2 (de) * 1992-12-03 1997-07-10 Lothar Prof Dr Kanz Vermehrung hämatopoetischer Vorläuferzellen ex vivo sowieZusammensetzungen hämatopoetischer Wachstumsfaktoren

Also Published As

Publication number Publication date
EP0830448A4 (en) 2001-12-05
AU5797496A (en) 1996-11-29
CA2221623A1 (en) 1996-11-21
WO1996036696A1 (en) 1996-11-21
EP0830448A1 (en) 1998-03-25
US5674750A (en) 1997-10-07

Similar Documents

Publication Publication Date Title
US5674750A (en) Continuous selective clonogenic expansion of relatively undifferentiated cells
US6338942B2 (en) Selective expansion of target cell populations
EP0730639B1 (en) Cell separation device
JP6661544B2 (ja) 遺伝子改変したｔ細胞の自動生成法
US5759793A (en) Method for mammalian cell separation from a mixture of cell populations
DE69033083T2 (de) Verfahren zur Fixierung und Rückgewinnung von Zellen
AU720285B2 (en) Process for preparing macrophages, and kits and compositions therefore
Hoover et al. T cells with Fc receptors for IgA: induction of T alpha cells in vivo and in vitro by purified IgA.
JPH078274A (ja) 膜バイオリアクター中の物質移動を改良する方法及び装置
DE69232682T2 (de) Verfahren zur selektiven vermehrung von cd34 positiven zellen
JP2004500095A (ja) 細胞の同時の刺激および濃縮
JP2006516197A (ja) 細胞の活性化および拡大の方法
EP4314244B1 (en) Cell capture and expansion
EP1453949B1 (en) Production of cell suspensions
JPS63502965A (ja) 免疫選択法
EP3528630A1 (en) Methods and systems for t cell expansion
Mandrusov et al. Membrane-based cell affinity chromatography to retrieve viable cells
EP1270719A2 (en) Cell population containing non-fetal hemangioblasts and method for producing same
AU752573B2 (en) Selective expansion of target cell populations
AU711528B2 (en) Continuous selective clonogenic expansion of relatively undifferentiated cells
JP4288352B2 (ja) 細胞の分離回収装置および分離回収方法
CA2221433A1 (en) Selective expansion of target cell populations
US20050202514A1 (en) Competitively Stable Target Cell Populations Isolated from Selectively Expanded Target Cell Populations
JPH01128796A (ja) 特に試薬の効率試験における細胞増殖方法
Morrill Characterization of the down regulation of antibody production in high cell density perfusion culture

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060912

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20061206

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070129

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20070427

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070605